Chief Physician, Second-Class Professor, Doctoral Supervisor Specializes in: Personalized precision diagnosis and treatment of various complex tumors. Main research areas and directions include translational research on precision diagnosis and treatment of gastrointestinal tumors, especially pancreatic cancer, multidisciplinary diagnosis and treatment of tumors, and individualized targeted and immunotherapy guided by clinical tumor genomics. Research Achievements: From 2001 to 2004, served as a visiting researcher at the University of California, Los Angeles (UCLA) and MD Anderson Cancer Center. Led the formulation of China's first "Chinese Expert Consensus on Comprehensive Diagnosis and Treatment of Pancreatic Cancer," the first "CSCO Guidelines for the Diagnosis and Treatment of Pancreatic Cancer" by the Chinese Society of Clinical Oncology, and the first "Guidelines for Tumor Nephropathy Protection Technology" by the Chinese Anti-Cancer Association. Presided over 7 National Natural Science Foundation projects, including a major research program, 2 major new drug development projects, and more than 10 various fund projects. Currently serves as Deputy Editor-in-Chief of the Journal of Pancreatology and other journals, and as an editorial board member of Cancer Research, JHO, and other journals. Has published more than 100 SCI papers, which have been cited more than 1,000 times. Research Directions: Led the formulation of China's first "Chinese Expert Consensus on Comprehensive Diagnosis and Treatment of Pancreatic Cancer" and the first "CSCO Guidelines for the Diagnosis and Treatment of Pancreatic Cancer" by the Chinese Society of Clinical Oncology. Presided over 6 National Natural Science Foundation projects, including a major research program, 2 major new drug development projects, and more than 10 various fund projects. Led the establishment of China's first "Pancreatic Tumor Internet Plus Consultation Platform" and China's advanced pancreatic tumor registration platform. Personal Honors: Awarded the First Prize of the Huaxia Medical Science and Technology Award (2023), the First Prize of the Shanghai Medical Science and Technology Progress Award (2022), and the Shanghai Medical Craftsman Award (2023), among others.